Physician profile
Gary R Schuster
NPI 1053500223
$15,533.40
in general payments reported to CMS, 2019-2025
66 companies · $2,096 in 2025
The $2,096 reported for 2025 was more than what 94% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,257 · 2020: $1,577 · 2021: $2,776 · 2022: $2,144 · 2023: $2,185 · 2024: $2,497 · 2025: $2,096.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,777 · Education: $1.77.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,777.26 |
| Education | $1.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,682.06 | 2019-2025 | Ubrelvy, Linzess, Vraylar |
| Amgen INC. | $1,549.04 | 2019-2025 | Repatha, Krystexxa, Repatha |
| Pfizer INC. | $1,432.94 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $1,228.55 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Biohaven Pharmaceuticals, INC. | $581.39 | 2020-2021 | |
| Novo Nordisk INC | $572.12 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Teva Pharmaceuticals USA, INC. | $557.04 | 2019-2025 | Ajovy, Austedo Xr |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $544.65 | 2019-2025 | Xifaxan |
| Lilly USA, LLC | $517.78 | 2019-2025 | Zepbound, Mounjaro, Jardiance |
| Biohaven Pharmaceutical Holding Company LTD. | $513.95 | 2022 | |
| Astellas Pharma US INC | $390.38 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $385.47 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $374.59 | 2019-2024 | Trintellix |
| Antares Pharma, INC. | $373.77 | 2019-2024 | Xyosted |
| Sanofi-Aventis U.S. LLC | $361.12 | 2019-2025 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $313.56 | 2021-2025 | Nexletol |
| Amarin Pharma, INC. | $268.33 | 2020-2021 | |
| Glaxosmithkline, LLC. | $265.65 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $241.77 | 2019-2024 | Jardiance |
| Allergan, INC. | $239.89 | 2019-2022 | |
| Idorsia Pharmaceuticals US INC | $228.09 | 2022-2024 | Quviviq |
| Phathom Pharmaceuticals, INC. | $182.84 | 2024-2025 | Voquezna |
| Kowa Pharmaceuticals America, INC. | $181.24 | 2019-2025 | Zoryve |
| Exact Sciences Corporation | $180.79 | 2023-2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $173.24 | 2019-2025 | Spravato |
| Regeneron Healthcare Solutions, INC. | $157.51 | 2019-2025 | Evkeeza |
| Arbor Pharmaceuticals, INC. | $134.07 | 2019-2022 | |
| Horizon Therapeutics Plc | $118.59 | 2019-2022 | |
| Jazz Pharmaceuticals INC. | $116.55 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $112.36 | 2022-2024 | |
| Azurity Pharmaceuticals, INC. | $110.88 | 2023-2025 | Horizant, Horizant |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $104.82 | 2023-2024 | Caplyta |
| Abbott Laboratories | $96.73 | 2025 | Freestyle Libre 3 |
| Genentech USA, INC. | $87.57 | 2019-2021 | |
| Lundbeck LLC | $81.30 | 2023 | Rexulti |
| Corium, LLC | $81.11 | 2022 | |
| Ibsa Pharma INC. | $66.26 | 2022-2023 | Tirosint, Licart |
| Merck Sharp & Dohme LLC | $66.20 | 2021-2023 | Verquvo, Belsomra |
| Ironwood Pharmaceuticals, INC | $60.00 | 2020 | |
| Impel Pharmaceuticals INC. | $56.86 | 2023 | Trudhesa |
| Aimmune Therapeutics, INC. | $52.39 | 2025 | Zenpep |
| Eisai INC. | $47.48 | 2020-2021 | |
| Vanda Pharmaceuticals INC. | $46.79 | 2025 | Fanapt |
| Ipsen Biopharmaceuticals, INC | $46.36 | 2022-2025 | Dysport |
| Bausch Health US, LLC | $44.68 | 2022-2024 | Wellbutrin, Aplenzin |
| Axsome Therapeutics, INC. | $37.46 | 2023 | Sunosi |
| Alfasigma USA, INC. | $36.18 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $36.06 | 2021-2024 | Eliquis |
| Medtronic, INC. | $32.35 | 2023 | Venaseal |
| Edwards Lifesciences Corporation | $31.28 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Hikma Pharmaceuticals USA | $27.70 | 2019 | |
| Ferring Pharmaceuticals INC. | $26.61 | 2019 | |
| Boston Scientific Corporation | $24.66 | 2023 | Watchman |
| Linus Health, INC. | $24.09 | 2024 | Core Cognitive Evaluation |
| Bardy Diagnostics, INC. | $24.06 | 2021 | |
| Grt US Holding, INC. | $21.32 | 2019 | |
| Tris Pharma INC | $21.29 | 2025 | Dyanavel Xr |
| Dexcom, INC. | $21.03 | 2024 | Dexcom G6 Transmitter |
| Xeris Pharmaceuticals, INC. | $20.58 | 2024 | Gvoke Hypopen |
| Impulse Dynamics (USA) INC. | $19.53 | 2022 | |
| Halozyme INC | $19.11 | 2023 | |
| Shire North American Group INC | $18.47 | 2019 | |
| Mdd US Operations, LLC | $16.82 | 2019 | |
| Pacira Therapeutics, INC. | $16.51 | 2019 | |
| Emd Serono, INC. | $15.58 | 2019 | |
| Echosens North America, INC. | $13.95 | 2023 | Fibroscan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Schuster listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.